Abstract

Life-threatening bacterial infections in women after childbirth, known as puerperal sepsis, resulted in classical epidemics and remain a global health problem. While outbreaks of puerperal sepsis have been ascribed to Streptococcus pyogenes, little is known about disease mechanisms. Here, we show that the bacterial R28 protein, which is epidemiologically associated with outbreaks of puerperal sepsis, specifically targets the human receptor CEACAM1. This interaction triggers events that would favor the development of puerperal sepsis, including adhesion to cervical cells, suppression of epithelial wound repair and subversion of innate immune responses. High-resolution structural analysis showed that an R28 domain with IgI3-like fold binds to the N-terminal domain of CEACAM1. Together, these findings demonstrate that a single adhesin-receptor interaction can drive the pathogenesis of bacterial sepsis and provide molecular insights into the pathogenesis of one of the most important infectious diseases in medical history.

Infection with Streptococcus pyogenes after childbirth can have life threatening consequences. Here, Catton et al. show that the epidemiologically associated bacterial R28 protein targets the human CEACAM1 receptor to facilitate the pathogenesis of bacterial sepsis.

Details

Title
Human CEACAM1 is targeted by a Streptococcus pyogenes adhesin implicated in puerperal sepsis pathogenesis
Author
Catton, Erin A. 1 ; Bonsor, Daniel A. 2 ; Herrera, Carolina 3 ; Stålhammar-Carlemalm, Margaretha 4 ; Lyndin, Mykola 5 ; Turner, Claire E. 6   VIAFID ORCID Logo  ; Soden, Jo 7 ; van Strijp, Jos A. G. 8   VIAFID ORCID Logo  ; Singer, Bernhard B. 9 ; van Sorge, Nina M. 10   VIAFID ORCID Logo  ; Lindahl, Gunnar 11   VIAFID ORCID Logo  ; McCarthy, Alex J. 12   VIAFID ORCID Logo 

 Imperial College London, Centre for Bacterial Resistance Biology, Section of Molecular Microbiology, Department of Infectious Diseases, London, UK (GRID:grid.7445.2) (ISNI:0000 0001 2113 8111) 
 University of Maryland, Baltimore, USA (GRID:grid.411024.2) (ISNI:0000 0001 2175 4264); Frederick National Laboratory for Cancer Research, NCI RAS Initiative, Cancer Research Technology Program, Frederick, USA (GRID:grid.418021.e) (ISNI:0000 0004 0535 8394) 
 Imperial College London, Section of Immunology of Infection, Department of Infectious Disease, London, UK (GRID:grid.7445.2) (ISNI:0000 0001 2113 8111) 
 Lund University, Department of Laboratory Medicine, Division of Medical Microbiology, Lund, Sweden (GRID:grid.4514.4) (ISNI:0000 0001 0930 2361) 
 Sumy State University, Sumy, Ukraine (GRID:grid.446019.e) (ISNI:0000 0001 0570 9340); University of Duisburg-Essen, Institute of Anatomy, Medical Faculty, Essen, Germany (GRID:grid.5718.b) (ISNI:0000 0001 2187 5445) 
 The University of Sheffield, The School of Biosciences, The Florey Institute, Sheffield, UK (GRID:grid.11835.3e) (ISNI:0000 0004 1936 9262) 
 Retrogenix, Chinley, High Peak, Chinley, UK (GRID:grid.11835.3e) 
 UMC Utrecht, Department of Medical Microbiology, Utrecht, The Netherlands (GRID:grid.7692.a) (ISNI:0000000090126352) 
 University of Duisburg-Essen, Institute of Anatomy, Medical Faculty, Essen, Germany (GRID:grid.5718.b) (ISNI:0000 0001 2187 5445) 
10  UMC Utrecht, Department of Medical Microbiology, Utrecht, The Netherlands (GRID:grid.7692.a) (ISNI:0000000090126352); Amsterdam UMC location University of Amsterdam, Amsterdam Institute for Infection and Immunity, Department of Medical Microbiology and Infection Prevention, Amsterdam, The Netherlands (GRID:grid.509540.d) (ISNI:0000 0004 6880 3010); Amsterdam UMC, location AMC, Netherlands Reference Laboratory for Bacterial Meningitis, Amsterdam, The Netherlands (GRID:grid.509540.d) (ISNI:0000 0004 6880 3010) 
11  Lund University, Department of Laboratory Medicine, Division of Medical Microbiology, Lund, Sweden (GRID:grid.4514.4) (ISNI:0000 0001 0930 2361); Lund University, Department of Chemistry, Division of Applied Microbiology, Lund, Sweden (GRID:grid.4514.4) (ISNI:0000 0001 0930 2361) 
12  Imperial College London, Centre for Bacterial Resistance Biology, Section of Molecular Microbiology, Department of Infectious Diseases, London, UK (GRID:grid.7445.2) (ISNI:0000 0001 2113 8111); UMC Utrecht, Department of Medical Microbiology, Utrecht, The Netherlands (GRID:grid.7692.a) (ISNI:0000000090126352) 
Pages
2275
Publication year
2023
Publication date
2023
Publisher
Nature Publishing Group
e-ISSN
20411723
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2803741698
Copyright
© The Author(s) 2023. corrected publication 2023. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.